Lon­za to in­vest $500M+ on fill-fin­ish fa­cil­i­ty on its home turf

Lon­za has been ex­pand­ing its reach across the globe, bring­ing sites in Chi­na and the US on­line this year, but now they are look­ing clos­er to home for their next ma­jor in­vest­ment.

The Swiss man­u­fac­tur­er on Fri­day an­nounced plans to con­struct a large-scale com­mer­cial drug fill and fin­ish fa­cil­i­ty in the town of Stein, Switzer­land. The new fa­cil­i­ty will be de­liv­ered through an in­vest­ment of ap­prox­i­mate­ly CHF 500 mil­lion, or $519 mil­lion, and is ex­pect­ed to be com­plet­ed in 2026. The fa­cil­i­ty will al­so be con­struct­ed on the same cam­pus as Lon­za’s cur­rent clin­i­cal drug prod­uct fa­cil­i­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER